H Gaertner

537 total citations
22 papers, 327 citations indexed

About

H Gaertner is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, H Gaertner has authored 22 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in H Gaertner's work include Schizophrenia research and treatment (6 papers), Treatment of Major Depression (5 papers) and Bipolar Disorder and Treatment (4 papers). H Gaertner is often cited by papers focused on Schizophrenia research and treatment (6 papers), Treatment of Major Depression (5 papers) and Bipolar Disorder and Treatment (4 papers). H Gaertner collaborates with scholars based in Germany, United States and Greece. H Gaertner's co-authors include U. Breyer-Pfaff, A Delcker, H. Giedke, Andreas Stevens, M. Bartels, Karl Mann, H. Bauer, B. Pflug, Hans‐Detlev Saeger and M. Koch and has published in prestigious journals such as Psychopharmacology, Psychiatry Research and Journal of Neural Transmission.

In The Last Decade

H Gaertner

21 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Gaertner Germany 11 177 91 57 41 34 22 327
C. B. Kristensen Denmark 12 94 0.5× 151 1.7× 44 0.8× 46 1.1× 15 0.4× 16 332
Klaus-Dieter Stoll Germany 9 189 1.1× 59 0.6× 73 1.3× 84 2.0× 46 1.4× 14 361
Peggy E. Hayes United States 10 64 0.4× 65 0.7× 42 0.7× 27 0.7× 25 0.7× 13 239
J. Bollen Belgium 4 248 1.4× 56 0.6× 39 0.7× 77 1.9× 45 1.3× 4 399
R Volmat France 10 118 0.7× 133 1.5× 66 1.2× 30 0.7× 14 0.4× 29 286
Sadanori Miura Japan 12 213 1.2× 52 0.6× 45 0.8× 59 1.4× 48 1.4× 22 374
Kalyna Z. Bezchlibnyk-Butler Canada 9 130 0.7× 56 0.6× 48 0.8× 30 0.7× 27 0.8× 13 277
Stephanie Pfister Denmark 7 357 2.0× 183 2.0× 32 0.6× 43 1.0× 67 2.0× 13 468
Ivo Caers Belgium 8 153 0.9× 40 0.4× 15 0.3× 34 0.8× 31 0.9× 10 327
Takahiko Inagaki Japan 10 29 0.2× 62 0.7× 58 1.0× 97 2.4× 35 1.0× 14 405

Countries citing papers authored by H Gaertner

Since Specialization
Citations

This map shows the geographic impact of H Gaertner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Gaertner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Gaertner more than expected).

Fields of papers citing papers by H Gaertner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Gaertner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Gaertner. The network helps show where H Gaertner may publish in the future.

Co-authorship network of co-authors of H Gaertner

This figure shows the co-authorship network connecting the top 25 collaborators of H Gaertner. A scholar is included among the top collaborators of H Gaertner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Gaertner. H Gaertner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaertner, H, et al.. (2002). A Case Control Study on Psychopharmacotherapy before Suicide Committed by 61 Psychiatric Inpatients. Pharmacopsychiatry. 35(2). 37–43. 19 indexed citations
2.
Kirsch, Christian, et al.. (2001). Sekundär hoch malignes MALT-Lymphom des Magens bei einem 69-jährigen Patienten mit gastrokolischer Fistel. Zeitschrift für Gastroenterologie. 39(1). 77–81.
3.
Nagel, Mato, et al.. (1999). Ungewöhnliches Bild eines Insulinoms bei Diabetes mellitus Typ 2 und morbider Adipositas. DMW - Deutsche Medizinische Wochenschrift. 124(9). 248–252. 13 indexed citations
4.
Stoelben, Erich, et al.. (1998). Spontaneous regression of hepatocellular carcinoma confirmed by surgical specimen: report of two cases and review of the literature. Langenbeck s Archives of Surgery. 383(6). 447–452. 27 indexed citations
5.
Stevens, Andreas, et al.. (1992). Haloperidol and Reduced Haloperidol Serum Levels: Correlation with Psychopathology in Acute Schizophrenia. Pharmacopsychiatry. 25(5). 218–223. 8 indexed citations
6.
Stevens, Andreas, et al.. (1992). Haloperidol and Lorazepam Combined: Clinical Effects and Drug Plasma Levels in the Treatmentof Acute Schizophrenic Psychosis. Pharmacopsychiatry. 25(6). 273–277. 11 indexed citations
7.
Delcker, A, et al.. (1990). Amisulpride Versus Haloperidol in Treatment of Schizophrenic Patients - Results of a Double-Blind Study. Pharmacopsychiatry. 23(3). 125–130. 58 indexed citations
8.
Gaertner, H, et al.. (1989). Side effects of clozapine. Psychopharmacology. 99(S1). S97–S100. 55 indexed citations
9.
Breyer-Pfaff, U., et al.. (1988). Single-dose kinetics of the neuroleptic drug perazine in psychotic patients. Psychopharmacology. 95(3). 374–7. 5 indexed citations
10.
Giedke, H., et al.. (1986). Psychophysiological Predictors of Antidepressant Therapy Response?. Pharmacopsychiatry. 19(4). 259–261. 1 indexed citations
11.
Gaertner, H, et al.. (1985). Serumspiegel von Pyridostigmin bei Myasthenia gravis: Methoden und klinische Bedeutung. Fortschritte der Neurologie · Psychiatrie. 53(6). 201–211. 5 indexed citations
12.
Mann, Karl, M. Bartels, H. Bauer, & H Gaertner. (1984). Amisulpride - An Open Clinical Study of a New Benzamide in Schizophrenic Patients. Pharmacopsychiatry. 17(4). 111–115. 14 indexed citations
13.
Breyer-Pfaff, U., et al.. (1982). Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels. Psychopharmacology. 76(3). 240–244. 33 indexed citations
14.
Gaertner, H, et al.. (1982). Response to Maprotiline Treatment in Depressive Patients Relationship to Urinary MHPG Excretion and Plasma Drug Level. Pharmacopsychiatry. 15(5). 170–174. 7 indexed citations
15.
Breyer-Pfaff, U., H Gaertner, & H. Giedke. (1982). Plasma levels, psychophysiological variables, and clinical response to amitriptyline. Psychiatry Research. 6(2). 223–234. 20 indexed citations
16.
Pflug, B., Wolfgang Engelmann, & H Gaertner. (1982). Circadian course of body temperature and the excretion of MHPG and VMA in a patient with bipolar depression. Journal of Neural Transmission. 53(2-3). 213–215. 9 indexed citations
17.
Gaertner, H, et al.. (1982). Do urinary MHPG and plasma drug levels correlate with response to amitriptyline therapy?. Psychopharmacology. 76(3). 236–239. 10 indexed citations
18.
Bartels, M., et al.. (1981). Acathisia-syndrome: Involvement of noradrenergic mechanisms. Journal of Neural Transmission. 52(1-2). 33–39. 7 indexed citations
19.
20.
Gaertner, H, et al.. (1969). [Relationship between the concentration of erythrocytes or hemoglobin and the hematocrit value as determined in the microhematocrit centrifuge of Janetzke].. PubMed. 22(13). 1225–31. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. B. Kristensen Breakdown of academic impact, for papers by Klaus-Dieter Stoll Breakdown of academic impact, for papers by Peggy E. Hayes Breakdown of academic impact, for papers by J. Bollen Breakdown of academic impact, for papers by R Volmat Breakdown of academic impact, for papers by Sadanori Miura Breakdown of academic impact, for papers by Kalyna Z. Bezchlibnyk-Butler Breakdown of academic impact, for papers by Stephanie Pfister Breakdown of academic impact, for papers by Ivo Caers Breakdown of academic impact, for papers by Takahiko Inagaki
Rankless by CCL
2026